ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LENZ LENZ Therapeutics Inc

15.58
0.54 (3.59%)
Jun 07 2024 - Closed
Delayed by 15 minutes

LENZ Therapeutics Financial Summary

The current LENZ market cap is 397.83M. The company's latest EPS is USD -4.8817 and P/E is -3.19.

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -26.75M-26.45M-58.16M-25.03M-25.56M
Net Income -24.6M-23.93M-55.31M-22.49M-22.92M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 000
Operating Income -60.44M-105.64M-135.19M
Net Income -70.76M-101.05M-124.65M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)
Total Assets 321.9M310M287.04M266.23M188.46M
Total Liabilities 25.61M33.77M62.9M62.21M4.87M
Total Equity 296.29M276.22M224.15M204.02M183.58M
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Assets 401.99M321.9M188.46M
Total Liabilities 17.94M25.61M4.87M
Total Equity 384.05M296.29M183.58M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)
Operating -87.98M-21.07M-34.73M-44.13M-90.01M
Investing -241.86M43.16M115.39M179.26M226.35M
Financing 597k-8k116k124k190k
Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Operating -52.85M-87.98M-90.01M
Investing -5.74M-241.86M226.35M
Financing 417.47M597k190k
Market Cap 397.83M
Price to Earnings Ratio -3.19
Price to Sales Ratio 0
Price to Cash Ratio 2.16
Price to Book Ratio 2.17
Dividend Yield -

Share Statistics

Shares Outstanding 25.53M
Average Volume (1 week) 144.52k
Average Volume (1 Month) 176.45k
52 Week Change -2.50%
52 Week High 24.59
52 Week Low 14.42
Spread (Intraday) 2.8 (16.02%)

Company Info

Company Name LENZ Therapeutics Inc
Address 1201 north market st
wilmington, delaware 19801
Website https://www.lenz-tx.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock